vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Upstart Holdings, Inc. (UPST). Click either name above to swap in a different company.
Upstart Holdings, Inc. is the larger business by last-quarter revenue ($308.2M vs $236.8M, roughly 1.3× CROSS COUNTRY HEALTHCARE INC). Upstart Holdings, Inc. runs the higher net margin — -2.2% vs -35.0%, a 32.9% gap on every dollar of revenue. On growth, Upstart Holdings, Inc. posted the faster year-over-year revenue change (44.4% vs -23.6%). Over the past eight quarters, Upstart Holdings, Inc.'s revenue compounded faster (55.4% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Upstart is an AI lending platform that partners with banks and credit unions to provide consumer loans using non-traditional variables, such as education and employment, to predict creditworthiness.
CCRN vs UPST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $308.2M |
| Net Profit | $-82.9M | $-6.6M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | -2.4% |
| Net Margin | -35.0% | -2.2% |
| Revenue YoY | -23.6% | 44.4% |
| Net Profit YoY | -2109.7% | -171.6% |
| EPS (diluted) | $-2.56 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $308.2M | ||
| Q4 25 | $236.8M | $296.1M | ||
| Q3 25 | $250.1M | $277.1M | ||
| Q2 25 | $274.1M | $257.3M | ||
| Q1 25 | $293.4M | $213.4M | ||
| Q4 24 | $309.9M | $219.0M | ||
| Q3 24 | $315.1M | $162.1M | ||
| Q2 24 | $339.8M | $127.6M |
| Q1 26 | — | $-6.6M | ||
| Q4 25 | $-82.9M | $18.6M | ||
| Q3 25 | $-4.8M | $31.8M | ||
| Q2 25 | $-6.7M | $5.6M | ||
| Q1 25 | $-490.0K | $-2.4M | ||
| Q4 24 | $-3.8M | $-2.8M | ||
| Q3 24 | $2.6M | $-6.8M | ||
| Q2 24 | $-16.1M | $-54.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — |
| Q1 26 | — | -2.4% | ||
| Q4 25 | -30.2% | 6.4% | ||
| Q3 25 | -2.4% | 8.5% | ||
| Q2 25 | -2.1% | 1.8% | ||
| Q1 25 | -0.3% | -2.1% | ||
| Q4 24 | -1.1% | -2.2% | ||
| Q3 24 | 0.9% | -27.8% | ||
| Q2 24 | -5.7% | -43.5% |
| Q1 26 | — | -2.2% | ||
| Q4 25 | -35.0% | 6.3% | ||
| Q3 25 | -1.9% | 11.5% | ||
| Q2 25 | -2.4% | 2.2% | ||
| Q1 25 | -0.2% | -1.1% | ||
| Q4 24 | -1.2% | -1.3% | ||
| Q3 24 | 0.8% | -4.2% | ||
| Q2 24 | -4.7% | -42.7% |
| Q1 26 | — | $-0.07 | ||
| Q4 25 | $-2.56 | $0.20 | ||
| Q3 25 | $-0.15 | $0.23 | ||
| Q2 25 | $-0.20 | $0.05 | ||
| Q1 25 | $-0.02 | $-0.03 | ||
| Q4 24 | $-0.13 | $-0.01 | ||
| Q3 24 | $0.08 | $-0.07 | ||
| Q2 24 | $-0.47 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $472.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $733.2M |
| Total Assets | $449.0M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $472.9M | ||
| Q4 25 | $108.7M | $652.4M | ||
| Q3 25 | $99.1M | $489.8M | ||
| Q2 25 | $81.2M | $395.9M | ||
| Q1 25 | $80.7M | $599.8M | ||
| Q4 24 | $81.6M | $788.4M | ||
| Q3 24 | $64.0M | — | ||
| Q2 24 | $69.6M | — |
| Q1 26 | — | $733.2M | ||
| Q4 25 | $322.8M | $798.8M | ||
| Q3 25 | $408.1M | $743.7M | ||
| Q2 25 | $412.2M | $722.0M | ||
| Q1 25 | $418.2M | $676.6M | ||
| Q4 24 | $419.0M | $633.2M | ||
| Q3 24 | $424.7M | $595.5M | ||
| Q2 24 | $433.3M | $594.7M |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $449.0M | $3.0B | ||
| Q3 25 | $538.2M | $2.9B | ||
| Q2 25 | $553.8M | $2.5B | ||
| Q1 25 | $576.2M | $2.3B | ||
| Q4 24 | $589.3M | $2.4B | ||
| Q3 24 | $597.4M | $1.8B | ||
| Q2 24 | $602.9M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $-133.3M |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-133.3M | ||
| Q4 25 | $18.2M | $108.6M | ||
| Q3 25 | $20.1M | $-122.6M | ||
| Q2 25 | $4.2M | $-120.2M | ||
| Q1 25 | $5.7M | $-13.5M | ||
| Q4 24 | $24.2M | $-110.9M | ||
| Q3 24 | $7.5M | $179.3M | ||
| Q2 24 | $82.4M | $65.3M |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | $108.4M | ||
| Q3 25 | $17.9M | $-122.7M | ||
| Q2 25 | $2.3M | $-120.3M | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | $179.2M | ||
| Q2 24 | $79.6M | $65.3M |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 36.6% | ||
| Q3 25 | 7.2% | -44.3% | ||
| Q2 25 | 0.8% | -46.7% | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | 110.5% | ||
| Q2 24 | 23.4% | 51.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 0.1% | ||
| Q3 25 | 0.9% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.6% | 0.0% | ||
| Q4 24 | 0.8% | 0.0% | ||
| Q3 24 | 0.4% | 0.1% | ||
| Q2 24 | 0.8% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.82× | ||
| Q3 25 | — | -3.86× | ||
| Q2 25 | — | -21.43× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
UPST
| Platform and referral fees, net | $224.6M | 73% |
| Servicing and other fees, net | $52.4M | 17% |
| Other | $31.2M | 10% |
